Clinical trial
Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
NCT00465296 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
- Lead sponsor
- Medstar Health Research Institute
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 31, 2006
- Completion date
- July 31, 2007
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.